PRTN3 and rheumatoid arthritis: Anti-citrullinated protein antibodies (ACPA) positive patients and subjects with psoriasis are two populations at higher risk of respectively developing rheumatoid arthritis (RA) and psoriatic arthritis (PsA) [1, 2].